Stand-alone Medicare drug plan premiums could jump 50% in 2027, analysis warns

If you receive your prescription drug coverage through a stand-alone Medicare Part D plan, your monthly bill may look dramatically different in the coming year.

A new analysis published by health policy research group KFF reveals that the average monthly premium for stand-alone Medicare prescription drug plans is projected to rise by 50% in 2027—jumping from $34 to $51 [KFF]. The finding comes as millions of older adults navigate open enrollment and weigh whether their existing coverage still fits their household budget.

The sharp increase applies to stand-alone prescription drug plans, known as PDPs, which are typically used by people enrolled in traditional Medicare alongside a supplemental policy [KFF]. KFF researchers emphasize that while the average premium across current plans is headed higher, enrollees can often avoid paying the steep increase if they actively shop the market and switch into lower-cost coverage [KFF].

The cost of staying on autopilot

For many beneficiaries, Medicare open enrollment can feel like a routine chore easily postponed. It is common practice to let coverage quietly roll over from one calendar year to the next, trusting that familiar terms will remain roughly unchanged.

Yet KFF’s projections suggest that passive renewal could carry an immediate financial penalty in 2027 [KFF]. Average monthly premiums for stand-alone plans have climbed significantly higher than those tied to Medicare Advantage plans with integrated drug benefits [KFF].

When insurers adjust their premium pricing or alter formulary structures, members who do not actively change their selections are automatically absorbed into the higher rates. In this case, remaining with your existing stand-alone drug plan could quietly add more than $200 per year to your out-of-pocket fixed costs before you ever step foot in a pharmacy [KFF].

Plan terminations add to the disruption

Rising premiums are not the only change heading for medicine cabinets across the country. According to companion research from KFF, more than 4 million Medicare beneficiaries will have their Medicare Advantage plan or stand-alone prescription drug plan terminated altogether at the end of 2026 [KFF].

When insurers withdraw specific plan offerings from regional markets, affected enrollees cannot rely on automatic continuity [KFF]. If your plan is among those exiting the market, you will be required to select a replacement policy or risk being reassigned under standard administrative rules, potentially losing preferred pharmacy networks or seeing specific medications shifted into higher cost-sharing tiers.

Combined with widespread premium shifts, these plan terminations mean that this fall’s open enrollment window demands more careful scrutiny than usual [KFF].

How to evaluate your drug coverage

If you want to protect your monthly cash flow heading into 2027, taking a few structured steps before enrollment deadlines arrive can make an outsized difference.

First, locate the Annual Notice of Change sent by your current plan provider. This document outlines your exact monthly premium for the coming plan year, as well as changes to your deductible and drug copayments. If you notice your premium creeping toward or past the projected $51 average, it is time to look at alternatives [KFF].

Second, gather an accurate list of all maintenance medications you currently take, including precise dosages. Enter them directly into Medicare’s official plan comparison tools to see how competing stand-alone plans categorize your prescriptions. A plan with a low monthly premium is not always a bargain if it moves your most critical daily medication into a specialty tier with high coinsurance.

Finally, check pharmacy networks carefully. Stand-alone Part D plans frequently contract with preferred retail pharmacies where copayments are lower. Confirming that your regular neighborhood pharmacy or preferred mail-order service remains in-network can help you capture savings without adding logistical friction to your routine.

Premiums may be projected to surge on paper, but you do not have to accept the increase quietly [KFF]. A single afternoon spent reviewing plan choices could be the difference between absorbing a 50% price hike and keeping your healthcare costs steady for the year ahead.